Émpar Mayordomo

1.1k total citations
16 papers, 829 citations indexed

About

Émpar Mayordomo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Émpar Mayordomo has authored 16 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Émpar Mayordomo's work include Sarcoma Diagnosis and Treatment (7 papers), Bone Tumor Diagnosis and Treatments (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Émpar Mayordomo is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Bone Tumor Diagnosis and Treatments (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Émpar Mayordomo collaborates with scholars based in Spain, Germany and United States. Émpar Mayordomo's co-authors include Carsten Denkert, Glen Kristiansen, Hans Guski, Edgar Dahl, Klaus‐Jürgen Winzer, Manfred Dietel, Peter Altevogt, Joachim Bellach, Christian Pilarsky and Karsten Schlüns and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Émpar Mayordomo

16 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Émpar Mayordomo Spain 12 428 277 264 153 112 16 829
Xiaopei Zhu United States 15 354 0.8× 344 1.2× 484 1.8× 107 0.7× 172 1.5× 22 1.1k
Dai Ikebe Japan 15 295 0.7× 252 0.9× 259 1.0× 100 0.7× 92 0.8× 26 912
Bruno Spina Italy 17 210 0.5× 291 1.1× 155 0.6× 184 1.2× 86 0.8× 59 916
Joanne I. Adamkewicz United States 13 219 0.5× 373 1.3× 155 0.6× 115 0.8× 47 0.4× 24 1.4k
Junliang Lu China 18 435 1.0× 334 1.2× 185 0.7× 253 1.7× 178 1.6× 48 961
Biagio Paolini Italy 20 305 0.7× 325 1.2× 213 0.8× 185 1.2× 89 0.8× 80 1.0k
Gabriella Sammarelli Italy 16 438 1.0× 404 1.5× 174 0.7× 109 0.7× 59 0.5× 39 938
Alice M. Walsh United States 13 344 0.8× 301 1.1× 260 1.0× 180 1.2× 100 0.9× 24 878
Silvia Brich Italy 18 468 1.1× 276 1.0× 746 2.8× 149 1.0× 142 1.3× 44 1.1k
T F Lioe United Kingdom 16 241 0.6× 204 0.7× 228 0.9× 149 1.0× 153 1.4× 30 797

Countries citing papers authored by Émpar Mayordomo

Since Specialization
Citations

This map shows the geographic impact of Émpar Mayordomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Émpar Mayordomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Émpar Mayordomo more than expected).

Fields of papers citing papers by Émpar Mayordomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Émpar Mayordomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Émpar Mayordomo. The network helps show where Émpar Mayordomo may publish in the future.

Co-authorship network of co-authors of Émpar Mayordomo

This figure shows the co-authorship network connecting the top 25 collaborators of Émpar Mayordomo. A scholar is included among the top collaborators of Émpar Mayordomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Émpar Mayordomo. Émpar Mayordomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mayordomo, Émpar, Eva González, Miguel Salavert, et al.. (2023). Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis. Transplant Infectious Disease. 25(4). e14067–e14067. 2 indexed citations
2.
Coloma, Carmen Salvador, Maria Saigí, Robert Díaz Beveridge, et al.. (2019). <p>Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas</p>. OncoTargets and Therapy. Volume 12. 9265–9275. 5 indexed citations
3.
Martín‐Broto, Javier, David Marcilla, Rafael Ramos, et al.. (2017). Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study.. Journal of Clinical Oncology. 35(15_suppl). 11071–11071. 2 indexed citations
4.
Sanz, Jaime, Marcos Arango, Leonor Senent, et al.. (2013). EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases. Bone Marrow Transplantation. 49(3). 397–402. 46 indexed citations
5.
Machado, Isidro, José Antonio López‐Guerrero, Samuel Navarro, et al.. (2013). Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(6). 665–671. 13 indexed citations
6.
Mayordomo, Émpar, Isidro Machado, Francisco Giner, et al.. (2010). A Tissue Microarray Study of Osteosarcoma: Histopathologic and Immunohistochemical Validation of Xenotransplanted Tumors as Preclinical Models. Applied immunohistochemistry & molecular morphology. 18(5). 453–461. 28 indexed citations
7.
Martí, Nuria, et al.. (2009). Successful Management of Kaposiform Hemangioendothelioma with Kasabach‐Merritt Phenomenon Using Vincristine and Ticlopidine. Pediatric Dermatology. 26(3). 365–366. 20 indexed citations
8.
Wang, Wei‐Lien, Émpar Mayordomo, Daniel Tuvin, et al.. (2009). Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Modern Pathology. 22(9). 1201–1209. 160 indexed citations
9.
Boscá-Watts, Marta Maia, et al.. (2008). Methotrexate induced sprue-like syndrome. World Journal of Gastroenterology. 14(45). 7009–7009. 25 indexed citations
10.
Wang, Wei‐Lien, Émpar Mayordomo, Bogdan Czerniak, et al.. (2008). Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Modern Pathology. 21(11). 1303–1310. 25 indexed citations
11.
Noguera, Rosa, Isidro Machado, Marta Piqueras, et al.. (2008). Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines. Diagnostic Pathology. 3(Suppl 1). S27–S27. 2 indexed citations
12.
Machado, Isidro, Francisco Giner, Émpar Mayordomo, et al.. (2008). Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study. Diagnostic Pathology. 3(S1). S25–S25. 15 indexed citations
13.
Gansukh, Tserenchunt, Carla A. Borgoño, Mick Burkhardt, et al.. (2006). Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status. British Journal of Cancer. 94(4). 540–547. 19 indexed citations
14.
Burkhardt, Mick, Émpar Mayordomo, Tserenchunt Gansukh, et al.. (2006). Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. Journal of Clinical Pathology. 59(4). 403–409. 104 indexed citations
15.
Fritzsche, Florian, Edgar Dahl, Stefan Pahl, et al.. (2006). Prognostic Relevance of AGR2 Expression in Breast Cancer. Clinical Cancer Research. 12(6). 1728–1734. 96 indexed citations
16.
Kristiansen, Glen, Klaus‐Jürgen Winzer, Émpar Mayordomo, et al.. (2003). CD24 expression is a new prognostic marker in breast cancer.. PubMed. 9(13). 4906–13. 267 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026